The ancillary companies that provide goods and services to the cannabis industry are legion. From equipment, real estate, legal services, and technology to packaging, labeling, intellectual property, hardware, and apparel, the list is basically endless for the opportunities that abound in the cannabis ancillary sector. One of the cooler ancillary areas that hasn’t gotten a ton of play is the cross section of telehealth and medical cannabis, especially where medical cannabis has overwhelmingly been deemed an essential service during COVID.
Just like state cannabis regulations, telehealth regulations vary by state. Telehealth (also known as telemedicine) is “. . . the distribution of health-related services and information via electronic information and telecommunication technologies.” The use of telehealth has seen a considerable uptick during the pandemic. And securing cannabis recommendations from physicians via telehealth apps or platforms is no exception. Of course, giving and securing a recommendation in this manner comes with some caveats. In this post, I focus specifically on California’s current relationship with telehealth and cannabis, which has thankfully evolved.
Telehealth compliance in California is governed by, among other things, Business & Professions Code, Section 2290.5. The Medical Board of California (“MBC”) also provides comprehensive guidance regarding telehealth as well